Skip to main content
Premium Trial:

Request an Annual Quote

Oxford BioDynamics Licenses EpiSwitch to Nova Satra in Asia

NEW YORK (GenomeWeb) – Oxford BioDynamics said today that its subsidiary, Oxford BioDynamics Pte, has signed an exclusive license agreement with Nova Satra Diagnostics Asia (NSDA) under which NSDA will be able to develop and commercialize non-invasive breast cancer testing across 13 territories in Asia using Oxford's EpiSwitch technology.

Under the terms of the agreement, NSDA will have the right to use the EpiSwitch technology platform and associated reagents for stratification of breast cancer patients. NSDA is solely responsible for completing any required regulatory approval processes and commercialization activities for the breast cancer test within the areas covered by the agreement.

In return, Oxford will receive an upfront licensing payment, royalties on sales of the test, and fees for certain undisclosed milestones, the company said. In Malaysia, Oxford has also agreed to allow NSDA to grant an exclusive sub-license to EpiSwitch to Genting Laboratory Services.

Nova Satra first announced that it was using technology from the University of Oxford to support a blood-based test for breast cancer last month, after receiving a $2 million investment from Genting Bio Cellular.

The Scan

International Team Proposes Checklist for Returning Genomic Research Results

Researchers in the European Journal of Human Genetics present a checklist to guide the return of genomic research results to study participants.

Study Presents New Insights Into How Cancer Cells Overcome Telomere Shortening

Researchers report in Nucleic Acids Research that ATRX-deficient cancer cells have increased activity of the alternative lengthening of telomeres pathway.

Researchers Link Telomere Length With Alzheimer's Disease

Within UK Biobank participants, longer leukocyte telomere length is associated with a reduced risk of dementia, according to a new study in PLOS One.

Nucleotide Base Detected on Near-Earth Asteroid

Among other intriguing compounds, researchers find the nucleotide uracil, a component of RNA sequences, in samples collected from the near-Earth asteroid Ryugu, as they report in Nature Communications.